Recursion Pharmaceuticals (RXRX) Acquisitions (2023 - 2024)
Recursion Pharmaceuticals (RXRX) posted Acquisitions of -$277.1 million for Q4 2024, compared with $71,000 a year earlier.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Acquisitions (2023 - 2024) Analysis & Trends
- In prior years, Recursion Pharmaceuticals' Acquisitions was -$1.84 million in FY2023 and $2.6 million in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.72 Bn | 1,125.31 Bn | 19.71 Bn | 8.75 Bn |
| 2 | Johnson & Johnson | 623.54 Bn | 542.07 Bn | 17.26 Bn | -17.24 Bn |
| 3 | AbbVie | 513.03 Bn | 486.14 Bn | 12.70 Bn | - |
| 4 | Merck | 365.42 Bn | 319.80 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.47 Bn | 261.46 Bn | 11.24 Bn | 23.00 Mn |
| 6 | Astrazeneca | 261.54 Bn | 235.23 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.13 Bn | 190.53 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.32 Bn | 167.51 Bn | 6.22 Bn | 11.21 Bn |
| 9 | Pfizer | 171.63 Bn | 118.28 Bn | 10.94 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.92 Bn | -681.11 Mn | -3.82 Mn | - |
API Access
Recursion Pharmaceuticals Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();